These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 17396743

  • 1. Yellow skin discoloration associated with sorafenib use for treatment of metastatic renal cell carcinoma.
    Dasanu CA, Alexandrescu DT, Dutcher J.
    South Med J; 2007 Mar; 100(3):328-30. PubMed ID: 17396743
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Managing adverse events associated with sorafenib in renal cell carcinoma.
    Edmonds K, Spencer-Shaw A.
    Br J Nurs; 2007 Mar; 19(1):58-60. PubMed ID: 20081715
    [Abstract] [Full Text] [Related]

  • 10. Sorafenib-induced erythema multiforme: three cases.
    Namba M, Tsunemi Y, Kawashima M.
    Eur J Dermatol; 2011 Mar; 21(6):1015-6. PubMed ID: 21926043
    [No Abstract] [Full Text] [Related]

  • 11. Sorafenib.
    Hasskarl J.
    Recent Results Cancer Res; 2010 Mar; 184():61-70. PubMed ID: 20072831
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapy.
    Yang CH, Lin WC, Chuang CK, Chang YC, Pang ST, Lin YC, Kuo TT, Hsieh JJ, Chang JW.
    Br J Dermatol; 2008 Mar; 158(3):592-6. PubMed ID: 18070211
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sorafenib-induced hand-foot skin reaction: a Koebner phenomenon?
    Sibaud V, Delord JP, Chevreau C.
    Target Oncol; 2009 Dec; 4(4):307-10. PubMed ID: 19894099
    [Abstract] [Full Text] [Related]

  • 20. Localized palmar-plantar epidermal hyperplasia associated with use of sorafenib.
    Cicek D, Kandi B, Dagli FA, Karaoglu A, Haligur BD.
    Clin Drug Investig; 2008 Dec; 28(12):803-7. PubMed ID: 18991474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.